Fresenius Medical Care AG & Co. KGaA
Research Fresenius Medical Care AG & Co. KGaA (FMS) on Bullrun: valuation model: 34.0% undervalued, market cap USD 12.51B, P/E 12.1, dividend yield 3.8%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerFMS
- ExchangeNYSE
- CountryGermany
- SectorHealthcare
- IndustryMedical Care Facilities
- CurrencyUSD
- Valuation signal34.0% undervalued
- Market capUSD 12.51B
- P/E12.1
- Dividend yield3.8%
- Financial periodQ2 2026
- RevenueEUR 4.86B
- Net incomeEUR 218.38M
- Free cash flowEUR 619.90M
- Gross margin27.0%
Valuation Snapshot
Bullrun's latest valuation model marks Fresenius Medical Care AG & Co. KGaA as 34.0% undervalued; latest market cap is USD 12.51B; P/E is 12.1; dividend yield is 3.8%.
Peer valuation comparison
Latest P/E is 12.13x versus a Healthcare sector median of 24.46x (50.4% below).
Latest dividend yield is 3.75% versus a Healthcare sector median of 2.11% (77.7% above).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | EUR 19.63B | EUR 978.37M | EUR 1.77B | 25.6% | 1.69 | EUR 1.58B | EUR 10.80B | EUR 13.31B |
| FY2024 | EUR 19.34B | EUR 537.89M | EUR 1.36B | 24.6% | 0.93 | EUR 1.15B | EUR 10.98B | EUR 14.58B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 12.51B | 12.1 | 3.7% | 0.87 |
| 2025 | 2025-12-31 | USD 13.81B | 12.4 | n/a | n/a |
| 2024 | 2024-12-31 | USD 13.29B | 22.9 | 2.8% | 0.63 |
| 2023 | 2023-12-29 | USD 12.22B | 25.4 | 3.0% | 0.62 |
| 2022 | 2022-12-30 | USD 9.59B | 11.6 | 4.3% | 0.71 |
| 2021 | 2021-12-31 | USD 19.02B | 16.6 | 2.6% | 0.83 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0.87 USD, yield 3.8%.
About Fresenius Medical Care AG & Co. KGaA
Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, the United States, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence;
Related stock research
Other Healthcare stocks
Frequently asked questions
Is Fresenius Medical Care AG & Co. KGaA overvalued or undervalued?
Bullrun's valuation model currently marks Fresenius Medical Care AG & Co. KGaA as 34.0% undervalued.
What is Fresenius Medical Care AG & Co. KGaA's market cap?
Fresenius Medical Care AG & Co. KGaA's market capitalization is USD 12.51B.
What is Fresenius Medical Care AG & Co. KGaA's P/E ratio?
Fresenius Medical Care AG & Co. KGaA's price-to-earnings (P/E) ratio is 12.1.
Does Fresenius Medical Care AG & Co. KGaA pay a dividend?
Fresenius Medical Care AG & Co. KGaA has a dividend yield of 3.8%.
What does Fresenius Medical Care AG & Co. KGaA do?
Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, the United States, and internationally.